Mass Tort Leads: How Lead Search Pros Screens to Your Criteria

Before a campaign launches, we build the screening questions from your firm's criteria for that litigation: product used, dates of use or exposure, diagnosis, and anything else you require. A claimant is only delivered after answering them.

When the same claimant is sold to several firms or aggregators, it can lead to duplicate signups and confusion over who represents them. Lead Search Pros sells leads from each campaign to one firm and never resells them.

Mass tort advertising is subject to state bar rules and sometimes specific disclosure requirements. Your firm approves final ad and landing page language, and we do not publish settlement amounts or promise outcomes.

Mass tort cases can take years. Every lead includes the source page, timestamp, IP address, consent, and the claimant's answers, so the record is there when you need it.

Every Lead Search Pros package is agreed and paid upfront, with no retainer and month-to-month terms with 30-day cancellation notice. Leads that turn out to be wrong numbers, duplicates, solicitors, or outside your agreed criteria and are reported within 72 hours are replaced free. That policy is published on our lead policy page so you can read it before you buy.

See the Mass Tort Leads page, our lead policy, or book a call to check availability in your market.

A mass tort lead is an inquiry from a person who believes an exposure, medication, device, or product may be connected to an injury and wants to discuss legal options. That is not a legal finding. It does not establish product use, causation, a diagnosis, timeliness, or eligibility for any particular litigation. A qualified marketing inquiry is one that fits the firm's agreed screening criteria well enough for an attorney-led review. The firm must still investigate and decide whether to accept representation.

Mass tort intake differs from a general personal injury form because the relevant product, exposure period, alleged injury, and documentation can vary from one litigation to another. A generic questionnaire asking only 'Were you injured?' will miss the fields a particular team needs. Conversely, a form demanding medical records before a person can ask a question may stop legitimate inquiries. The useful middle ground is a short, litigation-specific screen followed by a careful consultation.

Before buying leads, identify which matters your firm is actually accepting today. Do not assume a category remains active just because it once attracted publicity. Ask who updates the criteria, how quickly the campaign pauses if acceptance changes, and what happens to inquiries already in the pipeline. Honest marketing describes the opportunity to be evaluated, not an automatic right to compensation.

Begin with your firm's written acceptance rules. Which product or exposure is relevant? What date range matters to the firm? What type of diagnosis or treatment should intake note? Are there geographic restrictions, existing-counsel exclusions, or documentation requirements? Turn those into questions a layperson can answer without implying that an answer proves eligibility. The campaign should capture the person's account faithfully, including uncertainty.

A person may not remember an exact date or a product's full name. Decide whether approximate dates or alternate descriptions should trigger a follow-up rather than automatic rejection. If a specific diagnosis is central to your criteria, let the form record what the person reports and ask the attorney-led team to verify it. Do not ask the lead provider to pronounce a medical or legal conclusion based on a checkbox.

Review mock submissions before launch: an apparent match, a clear nonmatch, and a borderline case. Check how each will be routed and whether the landing page's language matches the accepted scope. Revisit the questions whenever the firm's criteria change. The quality of mass tort lead generation depends more on this alignment than on a broad promise of volume.

A medical device inquiry may need to identify a specific product and a person's reported experience after its use. A medication-related inquiry may depend on the product and the dates of use. A toxic exposure inquiry may involve a location and period of exposure. These are examples of different intake structures, not statements that a particular product caused an injury or that a lawsuit exists for it.

Avoid lumping every case into one advertisement promising a settlement. People need to know what the campaign is about, what information they will provide, who will contact them, and that a lawyer will evaluate their situation. If your firm is not accepting a category, remove its advertising instead of collecting inquiries that cannot receive the promised review. Keep campaign names and landing pages aligned with the actual litigation criteria your firm approved.

Build a record of the version of the screening questions used for each campaign. When criteria change, the same answer might be treated differently later. Versioning lets the firm explain why an inquiry was routed at the time it arrived. It also helps evaluate disputed leads fairly against the terms in effect at delivery, rather than applying a new rule after the fact.

Mass tort inquiries can circulate through multiple advertising channels. When a provider resells the same request to several firms, a claimant may receive repeated calls and become unsure who is reviewing the matter. Exclusive delivery means the provider sends the inquiry to one buyer under the agreed campaign arrangement. It does not prevent the person from independently contacting another firm, and it is not a guarantee that the person will sign.

Lead Search Pros describes each campaign's inquiries as going to one firm without resale to other firms or aggregators. Ask how a provider identifies duplicates within a campaign, which fields are checked, and what happens when a person submits the same form twice. Consider whether the person is already represented. Your intake team should ask respectfully rather than implying the marketing form settles the question of representation.

Do not treat 'exclusive' as a substitute for due diligence. Check the territory, campaign definition, lead source, and remedy if an inquiry is demonstrably duplicated or outside your criteria. An exclusive inquiry that does not fit the firm's current litigation criteria still creates work. A clear contract and a case-specific questionnaire matter more than a slogan.

Some firms evaluate mass tort matters across several jurisdictions; others limit intake to specific states or offices. Define exactly where the firm accepts inquiries and whether it can handle remote consultations. Geographic eligibility should be checked before a person submits detailed health information where possible. Do not advertise statewide or nationwide availability merely because a campaign platform can display ads that widely.

A firm serving Minnesota and Wisconsin, for instance, may need different location routing than a firm accepting inquiries only in Texas. These are planning examples, not claims about any state-specific filing rule. A location page should say what the firm actually offers in that place, how an individual can request a review, and any limitations the firm chooses to disclose. Replacing a state name in otherwise identical copy does not answer a visitor's real question.

When an alleged exposure occurred in one location and the person now lives elsewhere, collect both pieces of information if relevant to the firm's criteria. Do not let a marketing provider make a jurisdictional determination. Attorneys should evaluate the legal significance, including venue, deadlines, and any advertising obligations, using current authority and the facts of the individual matter.

Your firm should approve the final advertising and landing-page language before a campaign starts. That includes product names, descriptions of alleged harm, any disclaimers the firm requires, and statements about what happens after submission. Avoid unverified settlement figures, invented deadlines, or language that guarantees eligibility. If a product or litigation changes status, review the live copy promptly rather than leaving outdated claims in circulation.

People may disclose medical information in these forms. Collect only what is needed for the initial screen, explain the contact process, and provide a clear path for a private conversation. A consent record should reflect the exact language shown, the source page, the time of inquiry, and the details supplied. Lead Search Pros says consent is captured at submission and the records can be produced on request. Your firm remains responsible for its own contact and data-handling practices.

Attorney advertising rules differ by jurisdiction. Have ethics counsel review the campaign in the places where it runs, especially before making statements about a specific litigation or outcome. Do not suggest that submission creates an attorney-client relationship. A respectful, transparent request for information serves the claimant better than a message designed only to maximize form completions.

Assign a person or team to every new inquiry and keep the handoff documented. Check that the form identifies the correct campaign and that the key screening fields are present. Contact the person using methods supported by the consent they gave, confirm the basics without reciting sensitive facts in an insecure channel, and ask whether they have already retained counsel. An attorney or supervised team should then decide what documents and follow-up are appropriate.

Possible outcomes include not reached, reached and awaiting documents, outside current criteria, consultation scheduled, declined by the firm, or retained. Keep those distinct. A person who cannot locate a product record today is different from someone who answered a form with a clearly different product. Your team should decide whether a follow-up is warranted rather than marking every incomplete story as invalid.

Preserve the source, consent, question version, and delivery timestamp in an accessible record. If an inquiry is disputed, this gives both sides a way to compare the actual submission against the agreed campaign criteria. The objective is a defensible intake trail, not a form that pretends to resolve medical causation or legal merit.

Measure each campaign separately. Record leads delivered, people reached, criteria matches after review, consultations, retained claimants, and reasons matters did not proceed. If a firm's criteria change midway through the period, annotate that change. Combining several litigations in one headline conversion figure makes it difficult to learn whether the questionnaire, geography, or follow-up needs improvement.

Compare the package amount with the actual number of retained matters attributable to the leads, but do not assume every matter has the same value or will resolve. A mass tort may take substantial time to evaluate. A short reporting window can understate ongoing reviews, while a list of signed people says nothing about eventual case outcomes. Use your own observed process data rather than a provider's projected settlement or average-case-value claim.

If your firm rejects many people for the same reason, review the corresponding question and ad copy. If people cannot be reached, inspect contact methods and consent text. If the matters are potentially relevant but documents are missing, improve the handoff rather than simply buying more traffic. The scorecard should help the firm make decisions, not become a claim that any particular campaign guarantees results.

Lead Search Pros works from the firm's acceptance criteria. The firm and provider agree on price and package scope before payment upfront, then onboarding and campaign delivery follow. Confirm the litigation, territories, qualifying questions, accepted contact types, and any exclusions in writing. Do not pay for a broad category when your firm wants only a narrow subset and expect the provider to infer the difference later.

The lead policy provides for free replacement of approved non-qualified inquiries reported within 72 hours of delivery. Submit a brief reason and keep the delivery details for review. Approved reports are replaced with a new qualified lead rather than refunded or credited. A claimant deciding not to retain your firm is not by itself proof that the inquiry was invalid.

Review campaign changes as soon as your acceptance criteria change. If the firm stops taking a particular product or injury category, tell the provider to pause or revise targeting. Keep a record of when revised criteria take effect. This lets both parties judge future inquiries against the right version of the agreement.

Ask: Which litigation does this campaign cover? Who approved the final ad? What exact questions will a person answer? What happens when an answer is uncertain? Is every lead sold to one firm, and how are duplicates handled? Can your team review the source page and consent language? How are changes to case criteria communicated and dated? Answers to these questions are more useful than an unqualified promise of 'premium' leads.

Ask about delivery and follow-up too. Which system receives the inquiry, who sees the submitted answers, and how will a privacy-related concern be handled? What is the reporting window for an invalid inquiry, and what documentation does the provider need? Get the replacement terms before the package starts. Have the attorneys who supervise intake review both screening and advertising; marketing alone should not decide which matters the firm accepts.

See the mass tort leads service page for the category approach and schedule a conversation if your firm is actively accepting a specific litigation. Bring the current screening criteria and jurisdictions. Lead Search Pros can discuss a package around those inputs without claiming a case result, inventing a legal deadline, or treating a self-reported injury as proven.

A claimant-facing page should identify the particular product or exposure the firm is reviewing, the kind of information the firm will ask for, and the next step after submission. If a firm has not approved a diagnosis category or date range, do not present it as settled. The most helpful short answer to 'Do I qualify?' is often that an attorney needs to review the person's specific use, experience, records, and applicable law. That answer is less dramatic than a promise, but it is more honest.

Keep internal criteria and public copy synchronized. If the firm changes the matters it accepts, update the advertisement, landing page, screening form, and intake instructions together. A page built for one city or state should reflect the firm's actual service coverage there, not merely repeat a national claim with a local name. Search engines and AI systems may surface passages out of context, so each concise answer should still make clear that the inquiry is for evaluation and that results cannot be promised.

For a provider comparison, ask to see the actual questions and the consent wording rather than a sample headline. The claimant's path from answer to submission to attorney review should make sense on its own. Where a question cannot be answered reliably without medical records or counsel, say that plainly and offer a consultation. Accurate limitations are part of useful content, not an obstacle to it.